AtriCure, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for ATRC, updated each market day.
ATRC AI Sentiment
AI sees no strong directional signal for AtriCure, Inc. stock over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About AtriCure, Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Sector
Exchange
Market Cap
$3,007,215,301
Cap Tier
Employees
1,350
Headquarters
MASON, OH
Listed Since
Aug. 5, 2005
Website
ATRC Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ATRC Volatility
AtriCure, Inc. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
